Status: Not yet recruiting
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countries
Determine the long-term efficacy of clopidogrel compared with aspirin in reducing heart or brain attacks in patients with stable heart disease
Participants needed: 6,740
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Khalid F AlhabibUpdated: May 11, 2026
Eligibility criteria
Age ≥18 years. [+3]
History of hypersensitivity to aspirin or clopidogrel. [+6]